Revolution Medicines, Inc.
RVMD
Price:
$44.2
Market Cap:
$7.38B
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RA...[Read more]
Industry
Biotechnology
IPO Date
2020-02-13
Stock Exchange
NASDAQ
Ticker
RVMD
The ROE as of September 2024 (TTM) for Revolution Medicines, Inc. (RVMD) is -34.57%
According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current ROE is -34.57%. This represents a change of 276.28% compared to the average of -9.19% of the last 4 quarters.
Revolution Medicines, Inc. (RVMD) Historical ROE (quarterly & annually)
How has RVMD ROE performed in the past?
The mean historical ROE of Revolution Medicines, Inc. over the last ten years is -124.90%. The current -34.57% ROE has changed -72.32% with respect to the historical average. Over the past ten years (40 quarters), RVMD's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -12.95%.
Average
-124.90%
Median
-31.25%
Minimum
-686.98%
Maximum
-22.79%
Revolution Medicines, Inc. (RVMD) ROE by Quarter and Year
Discovering the peaks and valleys of Revolution Medicines, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.93%
Maximum Annual ROE = -22.79%
Minimum Annual Increase = -93.71%
Minimum Annual ROE = -686.98%
| Year | ROE | Change |
|---|---|---|
| 2023 | -23.89% | -34.17% |
| 2022 | -36.30% | 21.66% |
| 2021 | -29.83% | 30.93% |
| 2020 | -22.79% | -27.08% |
| 2019 | -31.25% | -27.72% |
| 2018 | -43.23% | -93.71% |
Revolution Medicines, Inc. (RVMD) Average ROE
How has RVMD ROE performed in the past?
The current ROE of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.01%
5-year avg
-28.81%
10-year avg
-124.90%
Revolution Medicines, Inc. (RVMD) ROE vs. Peers
How is RVMD’s ROE compared to its peers?
Revolution Medicines, Inc.’s ROE is greater than Blueprint Medicines Corporation (-85.25%), greater than Sana Biotechnology, Inc. (-71.60%), greater than Kymera Therapeutics, Inc. (-28.88%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than TCR2 Therapeutics Inc. (-89.51%), greater than Black Diamond Therapeutics, Inc. (-69.08%), greater than Atreca, Inc. (-195.22%), greater than Passage Bio, Inc. (-70.73%), greater than Akero Therapeutics, Inc. (-29.56%), greater than Avidity Biosciences, Inc. (-32.89%), less than Protagonist Therapeutics, Inc. (85.47%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Homology Medicines, Inc. (-100.91%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Agios Pharmaceuticals, Inc. (-47.05%), greater than Nurix Therapeutics, Inc. (-67.78%),
| Company | ROE | Market cap |
|---|---|---|
| -85.25% | $5.45B | |
| -71.60% | $986.64M | |
| -28.88% | $3.11B | |
| -70.40% | $359.95M | |
| -89.51% | $58.11M | |
| -69.08% | $312.47M | |
| -195.22% | $3.57M | |
| -70.73% | $46.26M | |
| -29.56% | $1.89B | |
| -32.89% | $4.90B | |
| 85.47% | $2.74B | |
| -57.89% | $773.40M | |
| -100.91% | $3.02M | |
| -44.60% | $437.87M | |
| -47.05% | $2.60B | |
| -67.78% | $1.64B |
Build a custom stock screener for Revolution Medicines, Inc. (RVMD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Revolution Medicines, Inc. (RVMD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Revolution Medicines, Inc.'s ROE?
How is the ROE calculated for Revolution Medicines, Inc. (RVMD)?
What is the highest ROE for Revolution Medicines, Inc. (RVMD)?
What is the 3-year average ROE for Revolution Medicines, Inc. (RVMD)?
What is the 5-year average ROE for Revolution Medicines, Inc. (RVMD)?
How does the current ROE for Revolution Medicines, Inc. (RVMD) compare to its historical average?